SIM
COLL icon

Spark Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Spark Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,400
Closed -$255K – 412
2019
Q2 		$255K Sell
19,400
-60,136
-76% -$804K 0.02% 439
2019
Q1 		$1.2M Buy
+79,536
New +$1.27M 0.06% 318
2015
Q3 		– Sell
-34,200
Closed -$608K – 688
2015
Q2 		$608K Buy
+34,200
New +$591K 0.08% 315

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Spark Investment Management's COLL Position: Q3 2019 in Review

Spark Investment Management sold out of Collegium Pharmaceutical (COLL) in Q3 2019, closing a stake of 19,400 shares — an estimated $255K sold.

Spark Investment Management first reported a position in COLL in Q2 2015 and held it in 3 quarters. The position peaked at $1.2M in Q1 2019. 117 funds tracked by Wall St. Rank hold COLL as of Q3 2019.

  • Spark Investment Management reported no remaining Collegium Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Spark Investment Management sold 19,400 Collegium Pharmaceutical shares in Q3 2019, an estimated $255K.
  • Spark Investment Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 3 quarters.
  • Spark Investment Management's Collegium Pharmaceutical position peaked at $1.2M in Q1 2019.
  • 117 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.